Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Mysterious Cause of Fatigue, Obesity, and Migraines Discovered
  • USA - English


News provided by

James Schaller, MD

Sep 17, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX


It took Dr. Schaller years to understand the power of Babesia to disable and kill.

Post this

(PRWEB) September 17, 2014 -- Dr. James Schaller specializes in treating mystery illnesses. He is a Sherlock Holmes of the medically abandoned. He has authored over 40 books and top journal articles that offer secrets to patient recovery. In the last decade, he has come across a critical cause of fatigue, obesity, and migraines missed by sincere and talented physicians. What is this stealth cause of these three major disabling conditions? It is a single-celled parasite that is carried by ticks and possibly also passes through the womb called Babesia. Dr. Schaller has written numerous books on this single-celled parasite, along with other academic papers. Like malaria, it lives inside red blood cells.

To learn more about Dr. Schaller, please visit: http://www.personalconsult.com

Dr. Schaller explains, “It took years to understand the power of Babesia to disable and kill. I used routine simple Babesia testing that showed it was very rare. Then a friend and doctor asked for my help in trying to cure his serious blood cancer. It almost killed him. After repeated negative Babesia test results, a trial of malaria medicines at very safe low doses suddenly created a positive Babesia antibody result.”

This patient’s worst symptoms included horrible migraine headaches, fatigue, and some muscle wasting. Dr. Schaller has since come to believe that most Babesia patients gain weight, but weight loss is also possible. Death can result from the dissolving of red blood cells or from blood clots. Dr. Schaller has found that patients with Babesia usually clot faster on testing, and is concerned it may increase heart attacks and strokes, yet Babesia is seldom diagnosed as the cause or even a contributing factor.

About a hundred years ago, Babesia decimated the cattle population in the southern US. According to many infection experts, Babesia microti is regarded as the top risk to the US blood supply with no approved screening test. Some physicians feel Babesia is significantly under-reported in ticks and infected humans, in part due to the significant limitations of direct Babesia laboratory results, i.e., antibody tests or DNA tests which can be falsely negative. Unfortunately, while Babesia has many treatment options, it is still felt to be rare in ticks and limited to only a select set of regions. Physicians with more experience with the diagnosis of Babesia, find Babesia in patients living in all USA states, all the provinces of Canada and all over the world. At times the best testing is indirect testing—checking for what Babesia does to a number of laboratory results as opposed to direct DNA testing for only one Babesia species.

This infection may be the most dangerous tick-carried infection in the world. Dr. Schaller’s hope is that most physicians learn it can be one of the causes of fatigue, obesity, and migraines, and that they are more vigilant for its many symptoms found in his Babesia, Bartonella, and Lyme Disease Checklist book. He also hopes healers would become familiar with indirect testing since direct testing is so insensitive. For example, dangerous Babesia duncani cannot be tested by many laboratories, and those that offer an antibody test make the antibody number for a positive so high, few infected patients would appear positive.    

Dr. Schaller reports the science of Babesia is constantly improving, requiring him to revise his approach to diagnosis and treatment. “We have found that Babesia leaves an imprint in the biochemistry of the body, so indirect testing is very useful. We test less for Babesia, and test more often for what chemicals are changed by the presence of Babesia in an infected body. In addition, one thing most agree on is that Babesia can be killed, and if it is a cause of mild or severe fatigue, obesity or weight loss or migraines, that healing is possible. And every few years we have new synthetic and natural medicine tools, to keep us confident as we keep finding many new strains and even some new species.“

For further information, visit Dr. Schaller's website, http://www.personalconsult.com. Dr. Schaller is also available for phone consultations by filling out an online form at his web site or by calling 239.263.0133. He is licensed in Florida and has been researching tick medicine full time for a decade.

References:

Luckett R, Rodriguez W, Katz D. Babesiosis in pregnancy.Obstet Gynecol. 2014 Aug;124(2 Pt 2 Suppl 1):419-22. http://www.ncbi.nlm.nih.gov/pubmed/25004307

Goodell AJ, Bloch EM, Krause PJ, Custer B. Costs, consequences, and cost-effectiveness of strategies for Babesia microti donor screening of the US blood supply.Transfusion. 2014 Sep;54(9):2245-57. http://www.ncbi.nlm.nih.gov/pubmed/25109338

J. Schaller. “Babesia” in Encyclopedia of Plagues, Pestilence and Pandemics, J. Bryre, Ed. Westport, CT: Greenwood Press; 2008. http://www.academia.dk/MedHist/Sygdomme/PDF/Encyclopedia_of_Pestilence_Pandemics_and_Plagues.pdf

J. Schaller, G. Burkland and P. Langhoff. “Is babesiosis a missed cause of hypereosinophilia? A five-year follow up on the first published case of Imatinib mesylate for idiopathic hypereosinophilia.” Medscape. Jan. 2007. http://www.ncbi.nlm.nih.gov/pubmed/17435644

J. Schaller, G. Burkland, “Rapid and complete remission of idiopathic hypereosinophilia with Gleevec: the first world case report.” Medscape. September 7, 2000. http://www.ncbi.nlm.nih.gov/pubmed/11698916

Contact Information, James Schaller, MD, http://www.personalconsult.com, +1 (239) 263-0133, [email protected]

Modal title

Babesia
Babesia
Dr. James Schaller
Dr. James Schaller
Babesia Dr. James Schaller

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.